The financing was led by Morpheus Ventures with participation from Nationwide Building Society.
"Percent was founded to become the global API-first infrastructure behind all giving. This will be the foundation for a better, fairer future of capitalism in which every financial transaction has social and environmental good built into it. The pandemic has accelerated a shift into the Decade of Purpose, in which people flock to like-minded brands who will help them create a better world. We enable that shift at a fraction of the cost, empowering companies to meet the demands of these new-look consumers. This latest round of investment to expand our work internationally shows that this message is resonating with businesses, their customers and nonprofits all over the world. It’s time to change capitalism for good."
The pre-seed round was led by Monzo founder Tom Blomfield and values the company at £5m.
"Lottie will be the care industry’s most advanced technology platform, optimised to simplify, streamline, and supercharge the care home search process. Care seekers are given the freedom to design their dream care experience on Lottie, while care partners benefit from higher resident admissions, increased revenue and a streamlined booking process. Our tech platform has been built with both care seekers and care providers in mind."
Pureland Global Venture led the Series B financing round to support the commercialisation of upright treatment technology.
"We founded Leo Cancer Care to revolutionize the Radiation Therapy space and achieving those sorts of goals only happens when you have incredible partners. Pureland Ventures has been amazing on this journey so far, so it is fantastic to have them lead this Series B financing round. It’s really exciting to see such a great balance of institutional and industry investments, it shows that the industry really shares in our vision for driving change."
The financing round was led by Stage 2 Capital and includes debt capital to fund further educational content.
"The go-to-market ecosystem has needed this solution for a long time. Internal learning and enablement resources are scrambling to equip their new hires with the same core sales, marketing, and customer success skills, and constantly reinventing the wheel from company to company,"
The financing round was led by Oxford Sciences Innovation to support the company in expanding its peptide discovery operations.
"Orbit’s team has the right combination of scientific rigor and novel peptide technologies to lead a new generation of drug development, and we look forward to partnering with the team to advance their mission,"
